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Introduction 
 
Many drugs used in clinical medicine are based on polyketide 
natural products.  Examples include antibiotics, anticancer agents, 
immunosuppressants and cholesterol-lowering statins [1].  The need 
for new therapeutics has motivated intensive research into the 
biosynthesis of these compounds.  Genetic engineering of producer 
micro-organisms has the potential to deliver libraries of new 
structures.  However, a better understanding of polyketide synthases 
(PKSs) would enable synthesis of larger and more diverse arrays, with 
eventual production of lead compounds in high yields at low cost. 
Polyketides are assembled from activated organic acids.  The 
process resembles fatty acid biosynthesis, in which the basic extension 
cycle adds a malonyl CoA derived two-carbon unit to a growing acyl 
chain [2].  The product is a β-ketoacyl thioester that is reduced to a 
β-hydroxyacyl intermediate, dehydrated to give a trans alkene, and 
reduced to give a saturated chain.  Repetition of this sequence gives a 
long-chain fatty acid.  Several enzymes catalyse this sequence of 
reactions.  Initially the starter acetyl unit is thioester-linked to the 
active site cysteine thiol of the ketosynthase (KS) enzyme. An 
acyltransferase (AT) transfers the dicarboxylic acid extender from 
CoA onto the phosphopantetheine thiol of the acyl carrier protein 
(ACP).  The KS catalyses a decarboxylative Claisen condensation to 
give an extended β-ketoacyl intermediate attached to the ACP.  
Ketoreductase (KR), dehydratase (DH) and enoylreductase (ER) 
enzymes catalyse the three processing steps.  Chain termination is 
catalysed by a thioesterase (TE).  Polyketide biosynthesis involves the 
same enzymes but generates a greater diversity of structures because 
the three-stage β-ketone processing sequence may be restricted, a 
variety of starters and extenders is used and chain lengths are more 
variable.  Polyketide carbon chains are more functionalised than fatty 
acids and  can  undergo  additional  reactions  such  as  intramolecular  
  
 
 
 
 
 
 
 
aldol condensation, macrolactonisation or polyether formation.  
Further late modifications include glycosylation, methylation, 
hydroxylation or halogenation [3, 4, 5].   
PKSs have been classified into three main groups [1].  With type I 
PKSs the constituent enzymes are covalently linked within 
multifunctional polypeptides.  Type II PKSs are composed of small 
discrete enzymes.  Type III PKSs are KSs that build carbon chains on 
CoA.  Type I PKSs may be iterative, with one set of biosynthetic 
enzymes catalysing several repetitions of an extension cycle, or 
modular, with multiple sets of enzymes catalysing a series of different 
cycles (Figure 1).  The AT-less type I modular PKS subgroup use 
discrete ATs to acylate all of the ACP domains within the assembly 
line.  Mixed systems composed of non-ribosomal peptide synthetase 
(NRPS) and PKS modules have the potential to synthesise an even 
greater diversity of structures [6].  
Complex polyketides frequently contain alkyl groups that result 
from incorporation of α-branched extender units, or from the action 
of methyltransferases that modify the C-2 position of a growing 
chain.  In some cases, structural complexity is increased further by β-
branching, where a β-ketone group undergoes a non-decarboxylative 
condensation with acetyl CoA.  The acetyl unit is eventually cleaved 
to leave a methyl group at a β position in the polyketide intermediate 
[7, 8].  Alkyl branching introduces chiral centres into polyketide 
chains, as does reduction of ketone groups to alcohols.  The ability to 
control these enzyme systems would enable efficient production of 
vast arrays of diverse polyketide structures for drug discovery.  The 
expanding knowledge of this area has been reviewed at regular 
intervals [9, 10, 11].  Type I, type II and type III PKSs have recently 
been reviewed by Hertweck [12].  This minireview will highlight 
some of the recent advances from biochemical studies on type I 
modular PKSs.   
 
6-Deoxyerythronolide B synthase    
 
The paradigm among complex PKSs is 6-deoxyerythronolide B 
synthase (DEBS), which makes the polyketide precursor of 
erythromycin A [13, 14].  The  essential  feature is  the  presence of  a  
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dedicated module for every cycle.  This design allows assembly of a 
defined sequence of starter and extender units, variable processing of 
β-ketone groups, and control of methyl and alcohol stereochemistry 
and double bond geometry.  
Early attempts at re-programming PKSs involved replacement of 
chromosomal coding sequences by homologous recombination within 
natural producer organisms.  This approach is slow and laborious but 
is still used to investigate larger systems such as polyene PKSs [15, 
16].  The first biochemical experiments relied on DEBS proteins 
purified from Saccharopolyspora erythraea [17].  Limited proteolysis 
was used to excise domains and didomains that could then be 
characterised and overexpressed as recombinant proteins [18].  PKS 
proteins are parallel homodimers [19].  C-terminal and N-terminal 
docking domains ensure that these proteins assemble into the correct 
order to give the final product [20].  The interactions between 
purified dimers are weak and overall enzymatic synthesis of 6-
deoxyerythronolide B (6-dEB) in vitro is barely detectable [17].  A 
simplified system was constructed by fusing the chain-terminating TE 
to the C-terminus of DEBS1 [21].  This bimodular PKS catalyses 
efficient synthesis of triketide lactones in vivo and in vitro. The DEBS 
proteins and the bimodular DEBS1-TE have been expressed in 
heterologous hosts, Streptomyces coelicolor and Escherichia coli 
strains engineered for phosphopantetheinylation and precursor 
production.  A library of over fifty 6-dEB analogues has been 
synthesised but in many cases yields were low [22, 23].  This 
represents only a fraction of the number of structures that is 
theoretically possible.  A deeper knowledge of modular PKSs is 
required to exploit these enzymes more effectively.   
Recombinant domains and didomains from DEBS have been 
characterised by x-ray crystallography and NMR spectroscopy [24, 
25, 26].  These include the KS3-AT3 and KS5-AT5 didomains, and 
the TE, KR1, DH4 domains.  NMR has been used to determine 
solution structures of ACP2 and ACP6 from DEBS and a fusion 
protein consisting of the C-terminal docking domain of DEBS1 
connected to the N-terminal docking domain of DEBS 2 [27].  The 
structure of an ER domain from the spinosyn PKS has been 
determined recently [28].  The structural studies have been 
comprehensively reviewed in the recent past [24, 25].  KR domains 
are of particular interest because they influence both methyl and 
alcohol stereochemistry.   
 
Ketoreductases 
 
PKS KR domains belong to the short-chain 
dehydrogenase/reductase family.  The active site contains a catalytic 
tetrad.  A Lys residue lowers the pKa of a Tyr hydroxyl group that 
protonates the β-ketone during hydride ion transfer.  These two 
residues are orientated by a conserved Asn, and a Ser helps bind the β-
ketone [29].  All of the active KR domains in DEBS use the 4-pro S 
hydrogen of NADPH [30, 31].   
The stereochemical outcome of a ketoreduction depends on the 
type of KR.  A-type KRs give 3D hydroxyl groups whereas B-type 
KRs give 3L [32].  For example, EryKR1 is B-type whereas Ery KR2, 
EryKR5, and EryKR6 are A-type (Figure 1).  In this review the 
Cahn-Ingold-Prelog nomenclature is used. In all of the structures 
discussed here, 3L and 3D hydroxyl groups are 3S and 3R 1. Ery KR1 
refers to the KR domain from module 1 of DEBS, the erythromycin 
PKS.  Likewise, Tyl, Amp, Pic and Spn refer to KRs from the tylosin, 
amphotericin, picromycin and spinosyn PKSs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 6-Deoxyerythronolide B synthase (DEBS).  DEBS contains a module for each of the 6 cycles of chain extension.  Each module catalyses incorporation 
of a (2S)-methylmalonyl CoA derived propionate unit into an acyl chain, to form a 2-methylbranched 3-ketoacyl intermediate.  The level of processing of the β-
ketone group is determined by the reduction domains.  Each module also determines the final stereochemistry of methyl- and hydroxyl-bearing centres.   
 
1 3D alcohols in polyketide intermediates are nearly always 
designated 3R in the CIP nomenclature system.  However, since 
polyketides in general can have variable substituents at C-2 and 
C-4, a 3D alcohol may be designated 3S in rare cases where C-4 
has a higher priority than C-2.  Similarly 3L alcohols are usually 
3S but may sometimes be designated 3R.  In 2-methyl-3-
ketoacyl-intermediates the thioester group invariably gives C-1 the 
highest priority so 2D methyl groups are always designated 2R 
and 2L methyl groups are always designated 2S.  For all of the 
structures discussed in this article 3R hydroxyl groups are 3D and 
3S hydroxyl groups are 3L.   
Polyketide biosynthesis 
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B-type KRs have a characteristic Leu-Asp-Asp (LDD) motif and 
conserved Pro and Asn residues [32, 33].  The second aspartate 
residue of the LDD motif is strictly conserved [28].  A-type KRs lack 
these motifs but contain a conserved Trp residue.  Most DH domains 
are paired with B-type KRs and give trans enoyl intermediates [32].  
This suggests that these double bonds are formed by dehydration of a 
(3R)-3-hydroxyacyl chains, as is the case in fatty acid biosynthesis.  
Some A- and B-type KRs occur in modules that incorporate 
methylmalonyl CoA derived extender units.  These have been 
subdivided further according to whether they act on (2R)- or (2S)-2-
methyl-3-ketoacyl substrates (see below).  
The activities of discrete recombinant KR domains have been 
tested using the model thioester substrate (2RS)-2-methyl-3-
ketopentanoyl N-acetylcysteamine (NAC, a surrogate for pantetheine) 
[34].  It is necessary to use racemic mixtures because spontaneous 
epimerisation of the methyl-branched centre is rapid in aqueous 
solution (the half-life for proton exchange in ethyl 2-
methylacetoacetate, a related β-ketoester, was 4.7 min [35]).   Some 
KRs (EryKR2, EryKR5, EryKR6) generated mixtures of up to 3 of 
the 4 possible stereoisomers of the 2-methyl-3-hydroxypentanoyl 
chain, with the “correct” product making up only a minor component 
of the mixture.  Others (EryKR1, TylKR1 and AmpKR2) formed 
reduced products with the same methyl and alcohol stereochemistry as 
their counterparts embedded in intact PKSs [34, 36].  
Saturation mutagenesis of the stereospecificity motifs was carried 
out by Leadlay and co-workers [37, 38].  Mutagenesis of the Leu-
Asp-Asp, Pro and Asn residues in Ery KR1 gave a switch in 
stereospecificity with (2RS)-2-methyl-3-ketopentanoyl -NAC or -
pantetheine thioester substrates; the product was (2S, 3S) rather than 
(2S, 3R) but activity decreased approximately 5-fold.  However, when 
the mutated KR was transplanted into intact DEBS1-TE the parent 
stereospecificity was observed, with the lactone of a (2S, 3R)-triketide 
being formed [39].  While these motifs are valuable for predicting the 
stereospecificity of a KR they do not per se determine stereochemical 
outcome.  The structure of the active site appears to be more 
important.   
The actions of some KRs on unnatural NAC or pantetheine 
thioesters are unpredictable.  They may show little selectivity towards 
the substrate with the correct methyl stereochemistry and may also fail 
to carry out stereospecific ketoreduction.  On the other hand, other 
KRs have potential as catalysts for stereospecific reduction of ketones 
in organic synthesis [40, 41]. 
A high-resolution crystal structure was first presented for Ery 
KR1 [42].  The structure revealed that the N-terminal region, 
previously regarded as an AT-KR interdomain linker, stabilises the C-
terminal domain that has catalytic activity.  An ER domain, when 
present in the reduction loop, is located between the structural and 
catalytic domains.  Structures are now available for several other KRs 
[43, 36, 44, 45].  The active site residues and the NADPH substrate 
have the same orientation in A- and B-type KRs, with the 4-pro-S-
hydrogen of the nicotinamide ring positioned toward the catalytic 
tyrosine.  The Leu-Asp-Asp and Trp motifs are on opposite sides of 
the catalytic groove.  The polyketide substrate is thought to enter the 
active site from opposite directions in A- and B-type KRs.  The two 
stereochemical outcomes result from presentation of different faces of 
the β-ketone group to the bound NADPH.  
 
Stereochemistry of condensation and ketoreduction steps  
 
Early studies revealed that the AT domains of all six DEBS 
extension modules use the (2S) stereoisomer of methylmalonyl CoA 
to acylate their ACPs [46].  Condensation occurs with inversion of 
stereochemistry at the methyl-branched carbon atom, so the initial 
product is (2R)-2-methyl-3-ketoacyl-ACP [47].  Some modules 
epimerise this intermediate to the (2S)-stereoisomer before the next 
step.  Once structural biology revealed exact domain boundaries, 
Khosla and Cane were able to reconstitute polyketide synthesis using 
active discrete KS, AT, ACP, KR and DH enzymes [48].  These 
Figure 2. Synthesis of triketide lactones using discrete ACPs and KS-AT didomains.  (2S, 3R)-2-methyl-3-hydroxypentanoyl-NAC is used to acylate the KS 
domain.  The AT uses (2S)-methylmalonyl CoA to load the ACP.  Condensation proceeds with inversion to give a (2R)-2-methyl-3-ketoacyl-ACP.  Triketide 
lactone products are identified by GC-MS.  Reduction of the ketone with borohydride prior to chain release gives a racemic mixture of (3R)- and (3S)- alcohols 
but fixes the (2R) methyl stereochemistry. Stereospecific ketoreduction can be achieved by adding a KR and NADPH.      
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domains co-operate in vitro to catalyse one cycle of chain extension.  
KS-AT didomains are considerably more active than separated KS 
and AT domains.  In these systems (Figure 2) the AT loads the holo-
ACP domain with a (2S)-methylmalonyl extender from CoA.  
Alternatively an apo-ACP can be modified with malonyl-pantetheine 
by a phosphopantetheinyltransferase.  The KS component of the KS-
AT didomain is primed with a synthetic (2S, 3R) 2-methyl-3-
hydroxypentanoyl chain that spontaneously migrates from NAC onto 
the active site cysteine.  This diketide is then extended.  The β-ketone 
group is reduced by inclusion of a KR domain and NADPH.  
Reduction fixes the C-2 methyl stereochemistry and prevents 
subsequent epimerisation.  The ACP-bound triketide products are 
released by base-catalysed hydrolysis and allowed to cyclise.  
Trimethylsilyl ethers of the resulting lactones are analysed by a 
sensitive GC-MS assay.  This method separates the 4 stereoisomers of 
the 2, 4-dimethyl-3, 5-dihydroxyheptanoic acid lactone that can form 
[(2R, 3S, 4S, 5R), (2R, 3R, 4S, 5R), (2S, 3R, 4S, 5R) or (2S, 3S, 
4S, 5R)].  The products of a reaction mixture are identified and 
quantified by comparison with synthetic standards [35].  
In 2-methyl-3-ketoacyl thioester intermediates, spontaneous 
epimerisation of the methyl-branched centre should be facile because 
of the acidity of the C-2 proton.  Early proposals suggested that 
epimerising modules can provide rapidly interconverting (2R)- and 
(2S)-2-methyl-3-ketoacyl-ACPs with only the (2S)- stereoisomers 
being selected by downstream enzymes. However, later work with the 
in vitro system revealed that KS3-AT3 and ACP3 form a (2R)-2-
methyl branched product that remains stable as long as it is attached 
to ACP3 [34].  It is thought that the hydrophobic cleft of the ACP 
protects the chain from water or prevents the β-ketone and thioester 
carbonyl groups from adopting a co-planar conformation.  While the 
reconstituted module 3 generates a (2R)-2-methyl-3-ketoacyl-ACP3 
thioester initially, the centre bearing this C-2 methyl group has the 
opposite stereochemistry in 6-dEB. This shows that C-2 
epimerisation occurs after condensation.   
There is now evidence that some KR domains catalyse both C-2 
epimerisation and 3-ketoreduction and thereby impose both the 
methyl and the alcohol stereochemistry.  Cane, Khosla and co-workers 
overexpressed KS-AT didomains and ACP domains from various C-2 
epimerising and non-epimerising modules.  Several discrete KRs were 
also used (Ery KR1, Ery KR6, Tyl KR1, Pic KR1) [49].  The 
reaction mixtures contained various combinations of KS-AT, ACP 
and KR proteins along with propionyl-NAC, methylmalonyl CoA 
and NADPH substrates.  Reduced diketide acid products were 
analysed by chiral GC MS.   
The KR domains showed increased specificity when provided 
with 3-ketoacyl-ACP rather than NAC thioester substrates.  Ery KR1 
gives a (2S, 3R) product, the same as DEBS module 1; Ery KR6 gives 
(2R, 3S), as does DEBS module 6; Tyl KR1 gives (2R, 3R) as does 
its parent module (Figure 3).  Presumably Amp KR1 or Amp KR11 
would give (2S, 3S) although this has not been tested.  These results 
indicate that when a module incorporates a propionate extender unit 
and reduces the ketone to an alcohol, the KR decides both methyl and 
alcohol stereochemistry.  Regardless of the source of the KS-AT and 
ACP, the initial product is a (2R)-2-methyl-3-ketoacyl-ACP. Some 
KRs reduce this directly whereas others apparently catalyse C-2 
epimerisation (to give a (2S)-2-methyl-3-ketoacyl-ACP) prior to 
ketoreduction, which fixes the methyl and alcohol stereochemistry.  It 
is less clear how an epimerised C-2 is maintained in cases where the β-
ketone group is not reduced.  Modules generating (2S)-2-methyl-3-
ketoacyl-ACP final products invariably contain defective KRo 
domains.  It has been proposed that these domains are inactive in 
ketoreduction but still catalyse C-2 epimerisation, with only the 
epimerised (2S)- form being accepted and fixed by the KS of the next 
module [43].  Ery KR3o is an example.  
     
 
 
 
 
 
 
 
 
 
 
 
A- and B-type KRs that act on 2-methyl-branched substrates have 
been divided into sub-groups according to the type of module in 
which they appear: A1 (not C-2 epimerising) and A2 (C-2 
epimerising), B1 (not C-2 epimerising) and B2 (C-2 epimerising) 
[43].  C-type KRs are reductase-incompetent. Those that encounter 
2-methyl substrates may occur in modules that are C-2 epimerising 
(C2 type) or not (C1 type).  Structures are now available for Ery KR1 
(B2), Tyl KR1 (B1), Amp KR2 (A1), Amp KR11 (A2), Pic KR3 
(C2) and Ery KR3 (C2) [36, 42-45].  Models for the structural basis 
of C-2 epimerisation have been discussed [43, 50].  The proposed 
mechanism involves removal of the α-proton, formation of an α-β 
enolate and re-protonation from the opposite side to invert the 
configuration of the methyl group.  Fingerprint motifs have been 
proposed for predicting methyl stereochemistry as well as alcohol 
stereochemistry [43].  In the case of the Amp KR2 (A1 type), 
mutagenesis of one of the fingerprint residues Gln364 to His gave an 
enzyme that converted (2RS)-2-methyl-3-ketopentanoyl-NAC 
substrates to 54% (2S, 3S) and 46% (2R, 3S) products rather than 
100% (2R, 3S) products [44]. An additional substitution 
Gly335Thr resulted in production of 94% (2S, 3S) diketides, 
essentially converting an A1 KR to an A2 [45].  Whether these 
mutations are sufficient to reverse methyl stereochemistry imposed by 
a complete PKS module remains to be seen.  Mutagenesis of the 
fingerprint His to Gln in the A2-type AmphKR1 reduced activity to 
6% but did not change the stereochemistry of NAC products.   
It has not been possible to demonstrate that recombinant Ery 
KR3o epimerises (2R)-2-methyl-3-ketopentanoyl-ACP thioesters 
formed by KS3-AT3 and ACP3 in the in vitro system [35].  
However, there is evidence that the KS downstream of a C2 KR is 
specific for a (2S)-2-methyl-3-ketoacyl chain.  Deletion of KR3o 
from DEBS resulted in termination after extension cycle 3 and 
formation of a tetraketide [44]. This is consistent with the hypothesis 
Figure 3.  In vitro synthesis of diketides.  The combinations of KS-AT and 
ACP used were DEBS KS1-AT1 + ACP1 (epimerising), DEBS KS3-AT3 + ACP3 
(epimerising), DEBS KS6-AT6 + ACP6 (non-epimerising), and PICS KS1-AT1 
+ PICS ACP1 (epimerising).  All combinations gave a (2R)-2-methyl-3-
ketoacyl-ACP initially. Enzymatic ketoreduction led to formation of a 2-
methyl-3-hydroxyacyl chain with the alcohol and methyl stereochemistry 
characteristic of the module from which the KR was derived.   
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that in the absence of KR3o, an un-epimerised (2R)-2-methyl-3-
ketoacyl chain is formed that is not extended by KS4.  The active site 
Tyr and Ser residues may allow alignment of the β-ketone and 
thioester carbonyls and thereby facilitate epimerisation.  Mutagenesis 
of both of these residues to Phe led to production of both the 
tetraketide and 6-dEB.  This suggested that the rate of epimerisation 
had been reduced [44].   
PKS reactions that determine stereochemistry involve acyl-ACP 
substrates.  There is increasing evidence that ACP domains make an 
important contribution to stereochemical outcomes.  (2RS)-2-
methyl-3-ketopentanoyl-NAC thioesters were used to prime triketide 
formation by a system composed of module 2 of the nanchangamycin 
synthase (NANS) fused to a TE domain [51].  Both the (2R)- and 
the (2S)- isomers were accepted by KS2 and extended with a 
methylmalonyl unit to form two triketide lactones.  However, when 
the  two primers were delivered from NANS ACP1 thioesters, only 
the (2S)-stereoisomer was accepted and extended.  The Km for the 
ACP donor was 300 times lower than that for the NAC thioester.  
This is further evidence that ACPn-KSn+1 interactions are important in 
determining methyl stereochemistry, particularly where the C-2 
epimerisation is not followed by ketoreduction [51].   
While the last module of the pikromycin PKS forms an 
unreduced (2R)-2-methyl-3-ketoacyl-ACP, none of the well-known 
PKSs forms an unreduced epimerised (2S)-2-methyl-3-ketoacyl-ACP 
thioester as a final product.  A highly selective TE might be required 
to discriminate between (2R)- and (2S)- 2-methyl-3-ketoacyl-ACP 
substrates in this instance.   
 
Dehydratases  
 
In fatty acid biosynthesis, DH enzymes act on (3R)-3-
hydroxyacyl-ACP thioesters and catalyse a syn elimination of water to 
give a trans double bond [52].  In PKSs most DH domains give trans 
double bonds and are paired with B-type KRs that give (3R)-3-
hydroxyacyl substrates. Inactivation of one of these DH domains 
should leave an alcohol of known stereochemistry. This has been 
verified experimentally for module 2 of the picromycin PKS [53].   
The DH4 domain of DEBS was shown to act only on (2R, 3R)-
2-methyl-3-hydoxypentanoyl-ACP4 to catalyse a syn elimination of 
water to form trans 2-methyl-pent-2-enoyl-ACP.  The other three 
stereoisomers ((2S, 3R), (2S, 3S), (2R, 3S)) were not dehydrated 
[54].  The reverse reaction was also demonstrated.  The reaction 
equilibrium favours the 3-hydroxyl form; however, the dehydrated 
form is rapidly consumed by the ER or the KS of the next module.  
The DH2 of the nanchangamycin PKS was also shown to act on a 
(2R, 3R)-2-methyl-3-hydoxyacyl-ACP substrate to form a trans 
double bond [55]. 
A DH catalysing a syn elimination of water from a (3S)- 3-
hydroxyacyl chain would be expected to give a cis double bond.  Some 
of the rare cis double bonds in complex polyketides appear to result 
from such dehydration reactions.  Plm1 and Plm2 from the 
phoslactomycin PKS and CurJ from the curacin NRPS-PKS are all 
unimodular proteins that contain DH domains paired with A-type 
KRs (the conserved Trp is present in all 3 whereas the Leu-Asp-Asp, 
Pro and Asn residues are absent) [56, 57].  All three modules generate 
cis double bonds.  Reynolds and co-workers obtained experimental 
evidence that Plm1 imposes the double bond geometry.  A cis enoyl 
chain was extended by Plm2 whereas the trans isomer was not 
incorporated intact [56].  Other cis double bonds in polyketides 
appear to arise from a different route as a late step, an example is 
found in borrelidin [58, 52]. A third cis double bond in 
phospholactomycin results from elimination of water as a post PKS 
modification [59]. 
 
Enoyl reduction  
 
In fatty acid biosynthesis NADPH is used to reduce a trans 
enoyl-ACP to a saturated acyl-chain.  In principle, the hydride ion can 
be added to either face of C-3 and either side of C-2 can be 
protonated.  There are four possible stereochemical routes, all of 
which are used by different FAS ERs from various organisms [51].  
In cycle 4 of erythromycin biosynthesis, the (2R)-2-methyl-3-
ketoacyl intermediate is reduced to a (2R, 3R)-2-methyl-3-
hydroxyacyl chain that is dehydrated to a trans 2-methyl-α-β-
unsaturated acyl-thioester.  This is then reduced by Ery ER4 to a 
(2S)-2-methyl-branched acyl chain.  The RAPS ER13 acts on a 
similar substrate but gives a (2R)-2-methyl-branched chain.   
Leadlay and co-workers have investigated the stereochemistry of 
enoyl reduction [60]. A triketide lactone synthase with a complete 
reduction loop (DH-ER-KR) in module 2 was used to test different 
ER domains.  A conserved Tyr (residue 51 with numbering from the 
domain start) was identified in ER domains giving (2S)-2-methyl-
branched products.  Mutagenesis of this residue Tyr51→Val resulted 
in a switch of methyl stereochemistry by the DEBS ER4 domain.  
However, the corresponding Val→Tyr mutation in the RAPS ER13 
did not give the reverse switch from (2R) to (2S) products.  Six other 
conserved residues were replaced by site-directed mutagenesis [61].  
None was found to be indispensable, but Lys236 may have a role in 
stereospecificity. One sixth of the triketide lactone made by the 
Lys236Ala mutant had reversed methyl stereochemistry at C-2.  This 
suggests that protonation may occur from the wrong side in the 
absence of the Lys236 side chain.    
The ERs of PKSs and FASs belong to the medium chain 
dehydrogenase/reductase (MDR) superfamily.  Keatinge-Clay and 
co-workers have recently crystallised a KR-ER didomain from the 
spinosyn PKS [28].  The Spn KR and ER are structurally similar to 
their counterparts in mammalian FAS but share a different interface 
with a greater surface area.  The isolated ER domain is monomeric.  
In PKSs the KS, DH, TE and N- and C-terminal docking domains 
are dimeric, the AT, KR and ACP domains are monomeric.  This is 
in contrast to mammalian FASs, in which the ER domain is dimeric 
and the TE domain is monomeric.  The PKS reduction loop is 
different because the ACP has to access all of the enzymes within the 
module despite being restricted by a dimeric element at the C-
terminus.  This constraint does not apply to mammalian FASs.  
Unlike KR domains, the ER uses the 4 proR hydride ion of 
NADPH.  The structure revealed that the Tyr51 and Lys236 residues 
examined by the Leadlay group are  within 5 Ao of the cofactor, along 
with a conserved Asp residue. 
 
ACP-KS interactions  
Mixing various KS-AT didomains with various ACP domains 
revealed that some combinations were more active than others in 
catalysing chain extension in vitro.  KS domains show some 
preferences towards ACP domains.  KS3 works with ACP3 and 
ACP5, less well with ACP2 or 4 and poorly with ACP1 or 6 [62, 
48].  ACP-KS interactions have been investigated by biochemical and 
computational methods. 
ACP domains are composed of three helices separated by two 
loops.  Phosphopantetheinyltransferases modify the Ser within the 
motif GXDSL, which is located at the N-terminus of helix II.  
Studies with ACP3/ACP6 hybrids revealed that loop I determines 
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whether the ACP recognises KS3-AT3 or KS6-AT6 in the in vitro 
chain elongation assay [63].  Modelling of this interaction indicates 
that the ACP interacts with a deep cleft formed by the KS, the KS-
AT interdomain linker and AT.  Mutagenesis of loop 1 revealed that 
residues 44 and 45 are important for molecular recognition by the 
KS-AT didomain. Further modelling indicates that these residues 
interact electrostatically with two sites within the KS-AT linker.  
Within a homodimeric PKS module, the ACP domain docks with the 
same polypeptide chain but co-operates with the KS in the opposing 
subunit to catalyse an elongation.  A hydrophobic patch on the KS 
interacts with the region surrounding the phosphopantetheinylated 
serine of ACP.        
Further mutagenesis was carried out to identify regions of the 
ACP that function in translocation of an extended polyketide to the 
next KS in the assembly line [64]. Ten residues at the N-terminus of 
helix I are important for transfer of a polyketide from ACPn to KSn+1.  
The residue at position 23 is critical in ACP-KS recognition for 
translocation.  For example, during transfer from DEBS module 4 to 
module 5, the translocation interactions principally involve Glu23 on 
helix 1 of ACP4 and Arg551 in the KS5-AT5 interdomain linker 
(Figure 4).  To effect translocation of the pentaketide, ACP4 
collaborates with KS5 by docking in the same deep cleft used by 
ACP5 during elongation.  However, the translocating ACP4 docks in 
a different position and orientation from that predicted for the 
elongating ACP5.  After completion of cycle 5, the hexaketide cannot 
translocate back to KS5 because the ACP5 residue corresponding to 
position 23 is His.  This does not form a translocation docking 
interaction with Arg551 in the KS5-AT5 interdomain region.  As a 
general pattern, the residue at position 23 in an ACP has the same 
charge as residue 551 of the KS-AT interdomain within the same 
module and the opposite charge to the corresponding position in the 
downstream module.  This prevents iterative operation of a module 
but allows forward translocation to the next KS.  The model for 
elongation and translocation interactions between ACP and KS 
domains is represented schematically in Figure 5.   
 
 
 
 
 
 
 
 
 
 
To test this hypothesis, Khosla and co-workers replaced helix I of 
ACP3 with helix I from ACP2.  The hybrid ACP was tested with 
KS3-AT3, (2S, 3R)-2-methyl-3-hydroxypentanoyl-NAC, (2S)-
methylmalonyl CoA, KR2 and NADPH [64].  The reconstituted 
module 3 catalysed two cycles of chain extension, indicating that the 
hybrid ACP could engage KS3 for elongation and translocation.  
Chain growth stopped after two cycles.  The active site of KS3 may 
not be able to accommodate a chain length greater than a tetraketide.  
The KR domain only reduced the ketone formed in the first of these 
two cycles.  
It will be interesting to see whether similar ACP-KS interactions 
impose unidirectional flow of extended intermediates in other PKSs.   
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions  
 
The modular nature of the erythromycin PKS was first recognised 
in 1990.  Since that time there has been considerable progress in 
understanding the enzymology of complex polyketide biosynthesis.  
Structural and biochemical studies have revealed many of the 
stereochemical aspects of the process.  Ketoreductase domains appear 
to determine methyl and alcohol stereochemistry in polyketide chains, 
although the precise mechanism by which some (2R)-2-methyl-3-
ketoacyl-ACP intermediates undergo C-2 epimerisation is still 
unclear.  Studies with recombinant discrete domains are revealing how 
best to achieve efficient synthesis of polyketides by artificially 
constructed assembly lines.  This should enable the full potential of 
PKSs to be exploited for synthesis of libraries of new compounds.  
 
 
 
 
 
 
 
 
 
Figure 4.  ACP4 docking interactions for elongation and translocation. A 
region of loop 1 functions in an elongation docking interaction with KS4-
AT4.  The N-terminal region of helix I engages in a translocation docking 
interaction with KS5-AT5.   
 
Figure 5.  Schematic representation of KS-ACP interactions in DEBS.  ACPn 
cannot transfer an extended polyketide back to KSn because their 
translocation epitopes are incompatible.  This prevents iterative operation 
of a module.  The elongation interactions are also electrostatic and are 
drawn to depict the preference of ACP3 for KS3 and KS5, the weak 
preference for KS2 and KS4 and the lack of co-operation with KS1 and KS6.  
The dashed arcs represent interdimer docking interactions between 
DEBS1 and DEBS2 and between DEBS2 and DEBS3.    
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